Page 59 - Human Use News Today

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

By Colin Kellaher Merck & Co. on Friday said the European Medicines Agencys Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer drug...

By Dean Seal Mirati Therapeutics said European regulators have issued a negative opinion on the conditional marketing authorization application for its drug...

By Sarah Sloat Swiss pharma company Roche said Friday it has received a positive opinion from the European Union that would extend use of its Evrysdi...

(RTTNews) - Mirati Therapeutics, Inc. (MRTX) announced the European Medicine Agencys Committee for Medicinal Products for Human Use issued a nega...

Opinion granted based on positive progression-free survival results from the Phase 3 KEYNOTE-811 trial If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of...

By Giulia Petroni The European Medicines Agency has recommended the approval of Ipsen's Bylvay treatment for cholestatic pruritus in patients with Alagille...

(RTTNews) - Bristol Myers Squibb Co.(BMY) Friday said it received positive opinion from the EMAs Committee for Medicinal Products for Human Use (...

By Chris Wack BeiGene said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending conditional marketing authorization to epcoritamab monotherapy for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma after 2 or more lines of systemic therapy.